Lumida
/CGEM
⌘K
Cullinan Therapeutics Inc

Cullinan Therapeutics Inc

CGEM
$20.59USD-1.95%-0.41 today

MARKET CAP

1.3B

P/E (TTM)

FWD P/E

DAY RANGE

$20 – $21

52W RANGE

$6
$23

AI Summary

Stalk
StalkMedium

CGEM is in a Stage 2 advancing structure, supported by a Bearish Exhaustion pattern suggesting sellers are losing control. However, the recent pullback through the rising 9 and 20 EMAs signals weakening short-term momentum. Price remains above the rising 50 SMA and 200 DMA, and RSI and Options Score are neutral, offering no immediate timing edge. Execution should be deferred until a shallow pullback is absorbed at the dynamic EMA support zone, confirming continued trend validity. A decisive close below the 50 SMA would invalidate the medium-term bullish bias.

  • Phase 3 trial for zipalertinib in NSCLC met primary PFS endpoint.
  • Six analysts rate CGEM a Buy with an average price target of $32.14.
  • Deep losses: adjusted Q2 EPS of –$0.81 vs –$0.80 estimate.
Full analysis →
Insider Trades55 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 13, 2026SellCGEMJennifer MichaelsonChief Scientific Officer60,000$12.28$1.3B-11.21%+262.50%$736.8K+0.00%10b5-1Buy Now
Jul 6, 2026SellCGEMJennifer MichaelsonChief Scientific Officer12,000$13.31$1.3B-11.21%+262.50%$159.8K-0.89%10b5-1Buy Now
Jun 30, 2026BuyCGEMMary Kay FentonChief Financial Officer1,541$8.60$1.3B-11.21%+262.50%$13.3K+1.22%16bBuy Now
Jun 30, 2026BuyCGEMJacquelyn L SumerChief Legal Officer2,470$8.60$1.3B-11.21%+262.50%$21.2K+1.93%16bBuy Now
May 5, 2026SellCGEMJennifer MichaelsonChief Scientific Officer12,000$11.18$1.3B-11.21%+262.50%$134.2K-0.64%10b5-1Buy Now
Mar 5, 2026SellCGEMJennifer MichaelsonChief Scientific Officer12,000$11.89$1.3B-11.21%+262.50%$142.6K-0.84%10b5-1Buy Now
Feb 25, 2026SellCGEMJennifer MichaelsonChief Scientific Officer1,780$14.14$1.3B-11.21%+262.50%$25.2K-1.01%10b5-1Buy Now
Feb 24, 2026SellCGEMJacquelyn L SumerChief Legal Officer3,601$14.47$1.3B-11.21%+262.50%$52.1K-2.73%Buy Now
Feb 24, 2026SellCGEMJeffrey Alan JonesChief Medical Officer4,582$14.47$1.3B-11.21%+262.50%$66.3K-2.78%Buy Now
Feb 24, 2026SellCGEMNadim AhmedPresident and CEO13,515$14.47$1.3B-11.21%+262.50%$195.6K-3.34%Buy Now
Feb 23, 2026SellCGEMJennifer MichaelsonChief Scientific Officer5,353$14.31$1.3B-11.21%+262.50%$76.6K-1.48%10b5-1Buy Now
Feb 20, 2026SellCGEMJacquelyn L SumerChief Legal Officer3,742$13.62$1.3B-11.21%+262.50%$51.0K-2.76%Buy Now
Feb 20, 2026SellCGEMMary Kay FentonChief Financial Officer4,398$13.62$1.3B-11.21%+262.50%$59.9K-3.36%Buy Now
Feb 20, 2026SellCGEMJeffrey Alan JonesChief Medical Officer4,982$13.62$1.3B-11.21%+262.50%$67.9K-2.94%Buy Now
Feb 20, 2026SellCGEMJennifer MichaelsonChief Scientific Officer19,742$10.12$1.3B-11.21%+262.50%$199.8K-0.55%10b5-1Buy Now
Feb 20, 2026SellCGEMNadim AhmedPresident and CEO16,381$13.62$1.3B-11.21%+262.50%$223.1K-3.89%Buy Now
Feb 12, 2026SellCGEMJennifer MichaelsonChief Scientific Officer416$12.03$1.3B-11.21%+262.50%$5.0K-0.32%Buy Now
Jan 22, 2026SellCGEMJennifer MichaelsonChief Scientific Officer4,000$12.30$1.3B-11.21%+262.50%$49.2K-3.02%10b5-1Buy Now
Dec 31, 2025BuyCGEMMary Kay FentonChief Financial Officer27$6.49$1.3B-11.21%+262.50%$175.23+0.04%16bBuy Now
Dec 23, 2025SellCGEMNadim AhmedPresident and CEO9,922$10.01$1.3B-11.21%+262.50%$99.3K-2.30%Buy Now
Dec 19, 2025SellCGEMJennifer MichaelsonChief Scientific Officer1,345$10.01$1.3B-11.21%+262.50%$13.5K-1.00%10b5-1Buy Now
Dec 18, 2025SellCGEMJennifer MichaelsonChief Scientific Officer2,898$9.67$1.3B-11.21%+262.50%$28.0K-2.12%Buy Now
Dec 18, 2025SellCGEMJacquelyn L SumerChief Legal Officer3,480$9.67$1.3B-11.21%+262.50%$33.7K-2.51%Buy Now
Dec 18, 2025SellCGEMJeffrey Alan JonesChief Medical Officer4,632$9.67$1.3B-11.21%+262.50%$44.8K-2.66%Buy Now
Dec 12, 2025SellCGEMJennifer MichaelsonChief Scientific Officer3,143$12.23$1.3B-11.21%+262.50%$38.4K-1.13%10b5-1Buy Now
Nov 24, 2025SellCGEMJennifer MichaelsonChief Scientific Officer4,000$12.30$1.3B-11.21%+262.50%$49.2K-2.82%10b5-1Buy Now
Feb 25, 2025SellCGEMJacquelyn L SumerChief Legal Officer3,756$8.53$1.3B-11.21%+262.50%$32.0K-2.67%Buy Now
Feb 25, 2025SellCGEMJennifer MichaelsonChief Scientific Officer3,756$8.53$1.3B-11.21%+262.50%$32.0K-2.58%Buy Now
Feb 25, 2025SellCGEMJeffrey Alan JonesChief Medical Officer4,895$8.53$1.3B-11.21%+262.50%$41.8K-2.73%Buy Now
Feb 25, 2025SellCGEMNadim AhmedPresident and CEO12,529$8.53$1.3B-11.21%+262.50%$106.9K-2.83%Buy Now
Jan 6, 2025SellCGEMJennifer MichaelsonChief Scientific Officer4,000$12.51$1.3B-11.21%+262.50%$50.0K-4.01%10b5-1Buy Now
Dec 24, 2024SellCGEMNadim AhmedPresident and CEO8,400$11.87$1.3B-11.21%+262.50%$99.7K-3.09%Buy Now
Dec 18, 2024SellCGEMJacquelyn L SumerChief Legal Officer3,482$11.41$1.3B-11.21%+262.50%$39.7K-3.70%Buy Now
Dec 18, 2024SellCGEMJeffrey Alan JonesChief Medical Officer4,632$11.41$1.3B-11.21%+262.50%$52.9K-3.90%Buy Now
Dec 18, 2024SellCGEMJennifer MichaelsonChief Scientific Officer4,693$11.41$1.3B-11.21%+262.50%$53.5K-4.49%Buy Now
Dec 12, 2024SellCGEMJennifer MichaelsonChief Scientific Officer3,489$12.52$1.3B-11.21%+262.50%$43.7K-3.23%Buy Now
Nov 5, 2024SellCGEMJennifer MichaelsonChief Scientific Officer8,000$15.64$1.3B-11.21%+262.50%$125.1K-6.90%10b5-1Buy Now
Sep 5, 2024SellCGEMJennifer MichaelsonChief Scientific Officer8,000$18.09$1.3B-11.21%+262.50%$144.7K-6.45%10b5-1Buy Now
Jul 5, 2024SellCGEMJennifer MichaelsonChief Scientific Officer8,000$16.33$1.3B-11.21%+262.50%$130.6K-6.06%10b5-1Buy Now
Jul 1, 2024BuyCGEMJennifer MichaelsonChief Scientific Officer2,360$9.00$1.3B-11.21%+262.50%$21.2K+1.82%Buy Now
May 6, 2024SellCGEMJennifer MichaelsonChief Scientific Officer119,212$17.08$1.3B-11.21%+262.50%$2.0M-0.79%10b5-1Buy Now
Feb 1, 2024SellCGEMCorrine SavillChief Business Officer80,000$10.24$1.3B-11.21%+262.50%$819.2K+0.00%10b5-1Buy Now
Jan 29, 2024SellCGEMCorrine SavillChief Business Officer80,000$9.20$1.3B-11.21%+262.50%$735.6K+0.00%10b5-1Buy Now
Jan 22, 2024SellCGEMCorrine SavillChief Business Officer75,875$8.52$1.3B-11.21%+262.50%$646.8K-0.44%10b5-1Buy Now
Dec 26, 2023SellCGEMNadim AhmedPresident and CEO4,272$9.24$1.3B-11.21%+262.50%$39.5K-3.69%Buy Now
Dec 21, 2023SellCGEMJennifer MichaelsonChief Scientific Officer1,145$8.50$1.3B-11.21%+262.50%$9.7K-1.29%Buy Now
Dec 21, 2023SellCGEMJacquelyn L SumerChief Legal Officer1,400$8.50$1.3B-11.21%+262.50%$11.9K-3.07%Buy Now
Dec 21, 2023SellCGEMJeffrey Alan JonesChief Medical Officer1,860$8.50$1.3B-11.21%+262.50%$15.8K-3.20%Buy Now
Dec 21, 2023SellCGEMJeffrey TrigilioChief Financial Officer1,920$8.50$1.3B-11.21%+262.50%$16.3K-2.24%Buy Now
Dec 18, 2023SellCGEMJennifer MichaelsonChief Scientific Officer238$8.22$1.3B-11.21%+262.50%$2.0K-0.27%Buy Now
Dec 18, 2023SellCGEMJacquelyn L SumerChief Legal Officer290$8.22$1.3B-11.21%+262.50%$2.4K-0.63%Buy Now
Dec 18, 2023SellCGEMJeffrey Alan JonesChief Medical Officer386$8.22$1.3B-11.21%+262.50%$3.2K-0.66%Buy Now
Dec 18, 2023SellCGEMJeffrey TrigilioChief Financial Officer398$8.22$1.3B-11.21%+262.50%$3.3K-0.46%Buy Now
Dec 12, 2023SellCGEMJennifer MichaelsonChief Scientific Officer1,068$7.81$1.3B-11.21%+262.50%$8.3K-1.19%Buy Now
Dec 12, 2023SellCGEMJeffrey TrigilioChief Financial Officer1,926$7.81$1.3B-11.21%+262.50%$15.0K-2.18%Buy Now